Journal article
Crossing the Shareholder-First Border: The Case of Trek Therapeutics
Proceedings of the International Association for Business and Society, v 30, pp 66-72
2019
Abstract
This project investigates critical issues and events related to Trek Therapeutics experience as a public benefit corporation. We will present and discuss how Trek differentiates itself in an industry where the attention is on high prices supporting high investor returns. Trek’s benefit corporation status helped it garner favorable attention in some respects, but has also presented challenges, particularly when it comes to attracting new capital.
Metrics
14 Record Views
Details
- Title
- Crossing the Shareholder-First Border
- Creators
- William P. SmithBarrie E. LitzkyInternational Association for Business and Society
- Publication Details
- Proceedings of the International Association for Business and Society, v 30, pp 66-72
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Charles D. Close School of Entrepreneurship
- Other Identifier
- 991021883908204721